[Immune checkpoint inhibitors-related severe hepatotoxicity in the treatment of non-small lung cancer: a case report].

Liu, D W; Fan, J T; He, X H; Hu, J R; Wang, Y X; Li, Z L

Liu, D W; Fan, J T; He, X H; Hu, J R; Wang, Y X; Li, Z L.

Affiliation

Liu DW; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
Fan JT; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
He XH; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
Hu JR; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
Wang YX; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
Li ZL; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.

Zhonghua Zhong Liu Za Zhi ; 43(12): 1325-1326, 2021 12 23.

Article in Zh | MEDLINE | ID: mdl-34915645

Subject(s)

Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Lung Neoplasms; Chemical and Drug Induced Liver Injury/etiology; Humans; Hyperplasia; Immune Checkpoint Inhibitors; Lung Neoplasms/drug therapy

Key words

Hepatotoxicity; Immune checkpoint inhibitors; IrAE; Lung neoplasms; Sintilimab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Chemical and Drug Induced Liver Injury / Lung Neoplasms Type of study: Etiology_studies Limits: Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2021 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google